David Altshuler - Net Worth and Insider Trading
David Altshuler Net Worth
The estimated net worth of David Altshuler is at least $11 Million dollars as of 2025-07-24. David Altshuler is the EVP, Chief Scientific Officer of Vertex Pharmaceuticals Inc and owns about 23,281 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $11 Million. Details can be seen in David Altshuler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Altshuler has not made any transactions after 2025-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Altshuler
David Altshuler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Altshuler owns 1 companies in total, including Vertex Pharmaceuticals Inc (VRTX) .
Click here to see the complete history of David Altshuler’s form 4 insider trades.
Insider Ownership Summary of David Altshuler
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2025-05-15 | EVP & Global Research and CSO |
David Altshuler Latest Holdings Summary
David Altshuler currently owns a total of 1 stock. David Altshuler owns 23,281 shares of Vertex Pharmaceuticals Inc (VRTX) as of May 15, 2025, with a value of $11 Million.
Latest Holdings of David Altshuler
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2025-05-15 | 23,281 | 474.54 | 11,047,766 |
Holding Weightings of David Altshuler
David Altshuler Form 4 Trading Tracker
According to the SEC Form 4 filings, David Altshuler has made a total of 34 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 0 buys and 34 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 52 shares on May 15, 2025, which brought David Altshuler around $22,084.
Insider Trading History of David Altshuler
- 1
David Altshuler Trading Performance
David Altshuler Ownership Network
Ownership Network List of David Altshuler
Ownership Network Relation of David Altshuler
David Altshuler Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
David Altshuler is the EVP & Global Research and CSO of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP & Chief Reg. & Quality Off. Ourania Tatsis , EVP & Chief Financial Officer Wagner Charles F Jr , and EVP & Chief Technical Ops. Off. Atkinson Edward Morrow Iii .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, David Altshuler made 11 insider transaction in Vertex Pharmaceuticals Inc (VRTX) with a net sale of 24,148. Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 17,021 shares made by Ourania Tatsis , a net sale of 16,449 shares made by Atkinson Edward Morrow Iii , and a net sale of 13,680 shares made by Carmen Bozic .
In summary, during the past 3 months, insiders sold 452 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 452 shares. During the past 18 months, 221,817 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 221,817 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
David Altshuler Mailing Address
Above is the net worth, insider trading, and ownership report for David Altshuler. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Altshuler's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
